tiprankstipranks
Trending News
More News >
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market
Advertisement

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Dividend Date & History

Compare
1 Followers
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
$4.08 (6.08%)
$112.91B
12.97
+24.15%
4 Buy
5 Hold
2 Sell
Hold
$1.11 (3.82%)
$209.43B
16.58
+42.34%
15 Buy
4 Hold
0 Sell
Strong Buy
$0.65 (16.97%)
$500.80M
-0.33
-65.02%
0 Buy
1 Hold
1 Sell
Moderate Sell
$6.7 (2.77%)
$226.82B
39.17
+19.98%
7 Buy
5 Hold
1 Sell
Moderate Buy
$6.76 (4.18%)
$328.81B
20.89
+11.87%
10 Buy
5 Hold
0 Sell
Moderate Buy
$3.835 (3.04%)
$68.15B
12.26
+2.00%
14 Buy
11 Hold
0 Sell
Moderate Buy
$1.305 (7.36%)
$60.83B
13.68
+10.54%
7 Buy
1 Hold
0 Sell
Strong Buy
$2.833 (6.86%)
$8.65B
15.33
+12.94%
3 Buy
2 Hold
0 Sell
Moderate Buy
$1.92 (8.6%)
$15.80B
10.93
+6.29%
11 Buy
2 Hold
0 Sell
Strong Buy

FAQ

How much is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's dividend?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) does not pay a dividend
When is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H ex-dividend date?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) does not pay a dividend.
When is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H dividend payment date?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) does not pay a dividend.
Does Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H have sufficient earnings to cover their dividend?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) does not pay a dividend.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis